Last $6.11 USD
Change Today -4.74 / -43.69%
Volume 16.6M
IMGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for immunogen inc (IMGN)

Year over year, ImmunoGen, Inc. has been able to grow revenues from $35.5M USD to $59.9M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 245.03% to 178.57%. This was a driver that led to an improvement in the bottom line from a loss of $72.8M USD to a smaller loss of $71.4M USD.
Currency in
Millions of US Dollars
As of:Jun 30
2011
Reclassified
Jun 30
2012
Reclassified
Jun 30
2013
Reclassified
Jun 30
2014
4 Year
Trend
Revenues19.316.435.559.9
TOTAL REVENUES19.316.435.559.9
Cost of Goods Sold58.969.287.1107.0
GROSS PROFIT-39.5-52.8-51.5-47.1
Selling General & Admin Expenses, Total20.620.421.524.5
OTHER OPERATING EXPENSES, TOTAL20.620.421.524.5
OPERATING INCOME-60.2-73.3-73.0-71.5
Interest and Investment Income0.20.10.10.0
NET INTEREST EXPENSE0.20.10.10.0
Currency Exchange Gains (Loss)0.1-0.20.00.1
Other Non-Operating Income (Expenses)1.20.00.00.0
EBT, EXCLUDING UNUSUAL ITEMS-58.6-73.3-72.8-71.4
Gain (Loss) on Sale of Investments0.3------
EBT, INCLUDING UNUSUAL ITEMS-58.3-73.3-72.8-71.4
Earnings from Continuing Operations-58.3-73.3-72.8-71.4
NET INCOME-58.3-73.3-72.8-71.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-58.3-73.3-72.8-71.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-58.3-73.3-72.8-71.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $6.11 USD -4.74

IMGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ablynx NV €9.18 EUR +0.121
BioInvent International AB kr2.48 SEK -0.04
Genmab A/S kr355.70 DKK +3.00
MorphoSys AG €77.95 EUR +0.90
Seattle Genetics Inc $32.89 USD -0.15
View Industry Companies
 

Industry Analysis

IMGN

Industry Average

Valuation IMGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.4x
Price/Book 8.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.